Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Fairfax, Virginia

Phase 1 cancer trials in Fairfax, VA

148 Phase 1 cancer studies are recruiting participants at sites in Fairfax as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Fairfax at a glance

Breast cancer studies recruiting in Fairfax

Basic details from each study's public record (the 30 most recently updated of 148). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    NEXT Oncology - Virginia Cancer Specialists
    Registry record
    NCT06253871 · updated
  2. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study sites
    Inova Schar Cancer Institute · Virginia Cancer Specialists, PC
    Registry record
    NCT06324357 · updated
  3. Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Inova Schar Cancer Institute ( Site 0051)
    Registry record
    NCT06686394 · updated
  4. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Inova Schar Cancer Institute Clinical Trials
    Registry record
    NCT07488676 · updated
  5. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Study sites
    Inova Schar Cancer Institute · NEXT Virginia
    Registry record
    NCT06270706 · updated
  6. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Stemline Therapeutics, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT06638307 · updated
  7. A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Prelude Therapeutics Incorporated
    Study site
    NEXT Virginia
    Registry record
    NCT07905001 · updated
  8. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    NEXT Texas LLC - Virginia
    Registry record
    NCT07503808 · updated
  9. Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    ORIC Pharmaceuticals
    Study site
    Next Oncology
    Registry record
    NCT05315700 · updated
  10. A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 19 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT06586957 · updated
  11. A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT07029399 · updated
  12. Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Study site
    USOR Virginia Cancer Specialists
    Registry record
    NCT05579366 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Fairfax, VA on ClinicalTrials.gov.

Lung cancer studies recruiting in Fairfax

  1. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Study site
    NEXT Virginia
    Registry record
    NCT05786924 · updated
  2. Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    LG Chem
    Study site
    NEXT Oncology
    Registry record
    NCT06332755 · updated
  3. A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Tyligand Pharmaceuticals (Suzhou) Limited
    Study site
    NEXT Virginia
    Registry record
    NCT06385925 · updated
  4. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT06983743 · updated
  5. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    NEXT Oncology Virginia
    Registry record
    NCT07277413 · updated
  6. A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT07730021 · updated
  7. A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BioNTech SE
    Study site
    NEXT Virginia
    Registry record
    NCT07111520 · updated
  8. Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study site
    Virginia Cancer Specialists, PC
    Registry record
    NCT04886804 · updated
  9. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Study site
    NEXT Oncology Virginia
    Registry record
    NCT07080242 · updated
  10. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kestrel Therapeutics, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT07458347 · updated
  11. A KRAS Inhibitor in Participants With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Ensem Therapeutics
    Registry record
    NCT07912593 · updated
  12. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Virginia Cancer Specialists
    Registry record
    NCT07020221 · updated
  13. A Study of DS-3939a in Participants With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Daiichi Sankyo
    Study site
    Inova Schar Cancer Institute
    Registry record
    NCT07739966 · updated
  14. A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    TRIANA Biomedicines, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT07491497 · updated
  15. Phase 1 Study of PF-08046033 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Inova Schar Cancer · Inova Schar Cancer Infusion Pharmacy
    Registry record
    NCT07519655 · updated
  16. A 2-part Phase 1/2 Open-label Trial on ODM-212

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Orion Corporation, Orion Pharma
    Study site
    NEXT Oncology Virginia
    Registry record
    NCT07563738 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Fairfax, VA on ClinicalTrials.gov.

Prostate cancer studies recruiting in Fairfax

  1. Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    NEXT Virginia
    Registry record
    NCT05997615 · updated
  2. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Amgen
    Study site
    Virginia Cancer Specialists PC
    Registry record
    NCT04221542 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Fairfax, VA on ClinicalTrials.gov.

Ask about studies near Fairfax

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call